Vue transversale globale
Toutes les maladies
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
8666 résultats correspondants
· 41 visibles sur cette page
dans le périmètre Toutes les maladies
Niveau clinique
Études et traitements 4050
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Greater Occipital Nerve Block with 0.9% saline Étude non communiquée | Migraine | Traitement symptomatique | Phase 4 | Terminé | The study was carried to determine the analgesic efficacy of greater occip… À vérifier | ClinicalTrials.gov 2023-01-11 | Détail |
| trans nasal sphenopalatine ganglion block Étude non communiquée | Sclérose en plaques | À vérifier | Phase 4 | Terminé | The purpose of the study is to compare Sphenopalatine ganglion block (SPGB… À vérifier | ClinicalTrials.gov 2023-01-10 | Détail |
| Stereotactic ablative radiotherapy (SABR) Étude non communiquée | Cancer | Ralentissement de la progression · Immunomodulation | Non applicable | Terminé | Irreversible electroporation (IRE) is a promising new ablation technique t… À vérifier | ClinicalTrials.gov 2022-12-18 | Détail |
| Sham Transcutaneous vagus nerve stimulation (Sham t-VNS) Étude non communiquée | Sclérose en plaques | Ralentissement de la progression · Traitement symptomatique | Non applicable | Terminé | Cardiovascular disease is one of the most important causes of death and di… À vérifier | ClinicalTrials.gov 2022-10-31 | Détail |
| Transcutaneous Sympathetic Ganglion Electrical Stimulation (t-SES) Étude non communiquée | Sclérose en plaques | Ralentissement de la progression · Traitement symptomatique | Non applicable | Terminé | Cardiovascular disease is one of the most important causes of death and di… À vérifier | ClinicalTrials.gov 2022-10-31 | Détail |
| EHP-101 25 mg BID Étude non communiquée | Sclérose en plaques | À vérifier | Phase 2 | Arrêté / suspendu | The purpose of this trial is to evaluate the safety, tolerability, pharmac… À vérifier | ClinicalTrials.gov 2022-10-19 | Détail |
| EHP-101 50 mg BID Étude non communiquée | Sclérose en plaques | À vérifier | Phase 2 | Arrêté / suspendu | The purpose of this trial is to evaluate the safety, tolerability, pharmac… À vérifier | ClinicalTrials.gov 2022-10-19 | Détail |
| EHP-101 50 mg OD Étude non communiquée | Sclérose en plaques | À vérifier | Phase 2 | Arrêté / suspendu | The purpose of this trial is to evaluate the safety, tolerability, pharmac… À vérifier | ClinicalTrials.gov 2022-10-19 | Détail |
| valsartan Étude non communiquée | Hypertension artérielle | À vérifier | Phase 3 | UNKNOWN | Resistant hypertension (RH) accounted for a considerable proportion of pat… À vérifier | ClinicalTrials.gov 2022-09-16 | Détail |
| Topiramate 25Mg Tab Étude non communiquée | Migraine | À vérifier | Non applicable | UNKNOWN | Migraine has been ranked as the second most disabling neurological disorde… À vérifier | ClinicalTrials.gov 2022-08-23 | Détail |
| Sorbitol Étude non communiquée | Maladie d’Alzheimer · Maladie de Parkinson | Remyélinisation · Remyélinisation indirecte / réparation | Phase 2 | Terminé | This double-blind, randomized, placebo-controlled, investigator-initiated,… À vérifier | ClinicalTrials.gov 2022-08-05 | Détail |
| Temelimab 36mg/kg Étude non communiquée | Sclérose en plaques | À vérifier | Phase 2 | Arrêté / suspendu | This Phase II study is a monocenter, long-term extension study of study GN… À vérifier | ClinicalTrials.gov 2022-07-04 | Détail |
| Radioactive iodine (Radioidine i131) Étude non communiquée | Cancer | Immunomodulation · Traitement symptomatique | Non applicable | Terminé | After obtaining informed consent, eligible subjects will be assigned rando… À vérifier | ClinicalTrials.gov 2022-05-19 | Détail |
| Moderate Dose Nicotine (14mg) Étude non communiquée | Maladie d’Alzheimer | À vérifier | Phase 1/2 | Terminé | This study will ascertain whether nicotine is safe and tolerable in DS pat… À vérifier | ClinicalTrials.gov 2022-05-06 | Détail |
| Ablation therapy (AT) Étude non communiquée | Cancer | Thérapie génique | À vérifier | Actif | Partial nephrectomy (PN) is the standard treatment for localized renal mas… À vérifier | ClinicalTrials.gov 2022-05-02 | Détail |
| Radical Nephrectomy (RN) Étude non communiquée | Cancer | Thérapie génique | À vérifier | Actif | Partial nephrectomy (PN) is the standard treatment for localized renal mas… À vérifier | ClinicalTrials.gov 2022-05-02 | Détail |
| Hepatic resection Étude non communiquée | Cancer | À vérifier | Non applicable | Arrêté / suspendu | This single-center, prospective, randomized clinical trial is designed to… À vérifier | ClinicalTrials.gov 2022-04-20 | Détail |
| LBR-101 Low Dose Étude non communiquée | Migraine | À vérifier | Phase 2 | Terminé | The purpose of this study is to determine whether monthly subcutaneous adm… À vérifier | ClinicalTrials.gov 2022-01-18 | Détail |
| Ocrelizumab 600 mg Étude non communiquée | Sclérose en plaques | À vérifier | Phase 4 | Terminé | This national, open-label study is designed to give complementary efficacy… À vérifier | ClinicalTrials.gov 2022-01-10 | Détail |
| Dexketoprofen Étude non communiquée | Migraine | À vérifier | Phase 4 | Terminé | In this study, the investigators planned to compare the effectiveness of a… À vérifier | ClinicalTrials.gov 2021-12-12 | Détail |
Découverte scientifique
Recherches et trouvailles 21
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Sclérose latérale amyotrophique | Neuroprotection · Immunomodulation | Découverte fondamentale | Exploratoire | Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… | Revue scientifique 2024-07-01 | Détail |
Bibliographie
Publications 4595
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Effects of testosterone-augmented multimodal exercise intervention in… Whole-body Electrical Muscle Stimulation Exercise · PMID 41988780 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source Spinal cord injury (SCI) leads to profound muscle atrophy, aerobic deconditioning, and metabolic dysfunction. Exercise-… | The Journal of clinical endocrinology and metabolism 2026-09-20 04:37:05 | Source |
| Feasibility and acceptability of whole-body electromyostimulation in… Whole-body Electrical Muscle Stimulation Exercise · PMID 42464389 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source Evidence on the effectiveness of electromyostimulation (EMS) has been reported in pulmonary rehabilitation, but the ben… | Pilot and feasibility studies 2026-09-20 04:37:05 | Source |
| Vestibular contributions adapt to the balance strategies adopted duri… Whole-body Electrical Muscle Stimulation Exercise · PMID 42616645 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source Vestibular contributions during walking are not uniform, but vary with gait phase, muscle group, and balance demands. M… | Journal of neurophysiology 2026-09-20 04:37:05 | Source |
| Clinical efficacy of abdominal moxibustion at the Zhongji (CV3) in co… Yangyin Roujin Decoction · PMID 42015783 | Myopathies | Neuroprotection · Traitement symptomatique | Publication | PubMed | Voir la publication source To investigate the clinical effect of abdominal moxibustion at the Zhongji (CV3) combined with Yiqi Tonglin Yangyin dec… | Journal of traditional Chinese medicine = Chung i tsa… 2026-09-20 04:37:03 | Source |
| Yiqi Huoxue Yangyin Decoction Ameliorates Diabetic Nephropathy by Tar… Yangyin Roujin Decoction · PMID 42713045 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source This study aimed to investigate the protective effects and underlying mechanisms of Yiqi Huoxue Yangyin Decoction (YHY)… | Diabetes, metabolic syndrome and obesity : targets and… 2026-09-20 04:37:03 | Source |
| Yiqi Huoxue Yangyin Decoction attenuates diabetic nephropathy in mice… Yangyin Roujin Decoction · PMID 42016924 | Myopathies | Thérapie génique | Publication | PubMed | Voir la publication source Diabetic nephropathy (DN) is a major complication of diabetes with limited therapeutic options. Yiqi Huoxue Yangyin Dec… | Frontiers in pharmacology 2026-09-20 04:37:03 | Source |
| Barcoded oligonucleotide system (BOLT) for targeted organ delivery. Immunotherapy · PMID 42733790 | Cancer | À vérifier | Publication | PubMed | Voir la publication source The therapeutic potential of oligonucleotides (oligos) is limited by insufficient delivery to extrahepatic tissues. In… | Bioactive materials 2026-09-20 04:36:56 | Source |
| Dual metabolic checkpoint blockade a 3D-Printed metalloplatform remod… Immunotherapy · PMID 42724565 | Cancer | Immunomodulation | Publication | PubMed | Voir la publication source The immunosuppressive tumor microenvironment limits the efficacy of therapies that target metabolism. Here we show a st… | Bioactive materials 2026-09-20 04:36:56 | Source |
| Oligosaccharide adjuvant-deferred antigen endocytosis promotes cross-… Immunotherapy · PMID 42751513 | Cancer | Immunomodulation · Thérapie génique | Publication | PubMed | Voir la publication source Antigen cross-presentation by dendritic cells (DCs) is essential for inducing cytotoxic immune responses, which are cru… | Bioactive materials 2026-09-20 04:36:56 | Source |
| Feasibility and safety of early discharge after robot-assisted uro-on… Digital care pathway for hypertension · PMID 42671715 | Hypertension artérielle | À vérifier | Publication | PubMed | Voir la publication source Early discharge after robot-assisted uro-oncologic surgery remains limited by concerns regarding patient safety and the… | Journal of robotic surgery 2026-09-20 04:36:49 | Source |
| HomeSafe: Postpartum Hypertensive Care Enabled by Electronic Health R… Digital care pathway for hypertension · PMID 41707683 | Hypertension artérielle | À vérifier | Publication | PubMed | Voir la publication source The objective is to present stepwise refinements to , an Epic-tethered, population-health-coordinated postpartum pathwa… | American journal of perinatology 2026-09-20 04:36:49 | Source |
| Nutraceutical and functional food: efficacy against metabolic disorde… Digital care pathway for hypertension · PMID 42603698 | Hypertension artérielle | Neuroprotection · Immunomodulation | Publication | PubMed | Voir la publication source The growing global emphasis on health consciousness has significantly increased demand for traditional and complementar… | Journal of advanced research 2026-09-20 04:36:49 | Source |
| Community-engaged design of a virtual diabetes prevention program int… Asynchronous communication with nurse · PMID 42288862 | Hypertension artérielle | À vérifier | Publication | PubMed | Voir la publication source The Diabetes Prevention Program (DPP) is an evidence-based approach to prevent Type 2 Diabetes (T2D), the leading cause… | BMC health services research 2026-09-20 04:36:48 | Source |
| Evolving Lung Cancer Navigator Practice Through Targeted Professional… Asynchronous communication with nurse · PMID 42463006 | Cancer | À vérifier | Publication | PubMed | Voir la publication source Lung cancer remains the leading cause of cancer deaths worldwide, and it has persistent disparities in detection, treat… | Chest 2026-09-20 04:36:48 | Source |
| Mass casualty training for prehospital and emergency providers in Kig… Asynchronous communication with nurse · PMID 42751142 | Hypertension artérielle | À vérifier | Publication | PubMed | Voir la publication source A mass casualty incident (MCI) occurs when the number of patients exceeds available healthcare resources, placing signi… | African journal of emergency medicine : Revue africain… 2026-09-20 04:36:48 | Source |
| Innovating a Teach-Back Model for Community Health Workers Led Health… Health Literacy Project · PMID 40194526 | Épilepsie | À vérifier | Publication | PubMed | Voir la publication source From 2021 to 2023, the City of Albuquerque, the University of New Mexico (UNM) Office for Community Health, the UNM Hos… | Health literacy research and practice 2026-09-20 04:36:34 | Source |
| Carotid intima-media thickness may be an early biomarker for cardiova… Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · PMID 41026111 | Épilepsie | À vérifier | Publication | PubMed | Voir la publication source To assess early signs of atherosclerosis following long-term treatment with the ketogenic diet therapy due to concerns… | Epilepsia open 2026-09-20 04:36:33 | Source |
| Impact of low-carbohydrate diet on health status: an umbrella review. Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · PMID 39385794 | Cancer | À vérifier | Publication | PubMed | Voir la publication source The prevalence of diet-related non-communicable diseases has increased. A low-carbohydrate diet (LCDs) is one of the mo… | Frontiers in nutrition 2026-09-20 04:36:33 | Source |
| The effect of anti-seizure medications on lipid values in adults with… Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · PMID 37244221 | Épilepsie | À vérifier | Publication | PubMed | Voir la publication source Certain anti-seizure medications (ASMs) adversely impact lipid values. Here, we explored the impact of ASMs on lipid va… | Epilepsy & behavior : E&B 2026-09-20 04:36:33 | Source |
| Possible role of locus coeruleus neuronal loss in age-related memory… The Role of the Locus Coeruleus in Age-related Distractibility · PMID 37694113 | Maladie d’Alzheimer | Immunomodulation | Publication | PubMed | Voir la publication source Aging is associated with a decline in cognitive abilities, including memory and attention. It is generally accepted tha… | Frontiers in neuroscience 2026-09-20 04:36:30 | Source |
Exploration — prudence
Pistes exploratoires 0
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune piste exploratoire ne correspond aux filtres. | |||||||